Literature DB >> 32007543

Prolonged Wireless pH Monitoring in Patients With Persistent Reflux Symptoms Despite Proton Pump Inhibitor Therapy.

Stephen Hasak1, Rena Yadlapati2, Osama Altayar1, Rami Sweis3, Emily Tucker4, Kevin Knowles4, Mark Fox5, John Pandolfino6, C Prakash Gyawali7.   

Abstract

BACKGROUND & AIMS: Wireless pH monitoring measures esophageal acid exposure time (AET) for up to 96 hours. We evaluated competing methods of analysis of wireless pH data.
METHODS: Adult patients with persisting reflux symptoms despite acid suppression (n = 322, 48.5 ± 0.9 years, 61.7% women) from 2 tertiary centers were evaluated using symptom questionnaires and wireless pH monitoring off therapy, from November 2013 through September 2017; 30 healthy adults (control subjects; 26.9 ± 1.5 years; 60.0% women) were similarly evaluated. Concordance of daily AET (physiologic <4%, borderline 4%-6%, pathologic>6%) for 2 or more days constituted the predominant AET pattern. Each predominant pattern (physiologic, borderline, or pathologic) in relation to data from the first day, and total averaged AET, were compared with other interpretation paradigms (first 2 days, best day, or worst day) and with symptoms.
RESULTS: At least 2 days of AET data were available from 96.9% of patients, 3 days from 90.7%, and 4 days from 72.7%. A higher proportion of patients had a predominant pathologic pattern (31.4%) than control subjects (11.1%; P = .03). When 3 or more days of data were available, 90.4% of patients had a predominant AET pattern; when 2 days of data were available, 64.1% had a predominant AET pattern (P < .001). Day 1 AET was discordant with the predominant pattern in 22.4% of patients and was less strongly associated with the predominant pattern compared with 48 hour AET (P = .059) or total averaged AET (P = .02). Baseline symptom burden was higher in patients with a predominant pathologic pattern compared with a predominant physiologic pattern (P = .02).
CONCLUSIONS: The predominant AET pattern on prolonged wireless pH monitoring can identify patients at risk for reflux symptoms and provides gains over 24 hours and 48 hours recording, especially when results from the first 2 days are discordant or borderline.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnostic; GERD; Gastroesophageal Reflux Disease; Prognostic

Year:  2020        PMID: 32007543      PMCID: PMC7392797          DOI: 10.1016/j.cgh.2020.01.031

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  22 in total

Review 1.  Interference with daily activities and major adverse events during esophageal pH monitoring with bravo wireless capsule versus conventional intranasal catheter: a systematic review of randomized controlled trials.

Authors:  A Iluyomade; A Olowoyeye; O Fadahunsi; L Thomas; C N Libend; K Ragunathan; J Fenster; S Vignesh
Journal:  Dis Esophagus       Date:  2017-02-01       Impact factor: 3.429

2.  Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease.

Authors:  Chandra Prakash; Ray E Clouse
Journal:  Clin Gastroenterol Hepatol       Date:  2005-04       Impact factor: 11.382

3.  The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.

Authors:  Nimish Vakil; Sander V van Zanten; Peter Kahrilas; John Dent; Roger Jones
Journal:  Am J Gastroenterol       Date:  2006-08       Impact factor: 10.864

4.  Forty-eight-hour pH monitoring increases sensitivity in detecting abnormal esophageal acid exposure.

Authors:  Daniel Tseng; Adnan Z Rizvi; M Brian Fennerty; Blair A Jobe; Brian S Diggs; Brett C Sheppard; Steven C Gross; Lee L Swanstrom; Nicole B White; Ralph W Aye; John G Hunter
Journal:  J Gastrointest Surg       Date:  2005-11       Impact factor: 3.452

5.  Ambulatory esophageal pH monitoring using a wireless system.

Authors:  John E Pandolfino; Joel E Richter; Tina Ours; Jason M Guardino; Jennifer Chapman; Peter J Kahrilas
Journal:  Am J Gastroenterol       Date:  2003-04       Impact factor: 10.864

6.  Esophageal acid sensitivity and mucosal integrity in patients with functional heartburn.

Authors:  P W Weijenborg; A J P M Smout; A J Bredenoord
Journal:  Neurogastroenterol Motil       Date:  2016-05-18       Impact factor: 3.598

7.  Long-term wireless pH monitoring of the distal esophagus: prolonging the test beyond 48 hours is unnecessary and may be misleading.

Authors:  G Capovilla; R Salvador; L Spadotto; G Voltarel; E Pesenti; A Perazzolo; L Nicoletti; S Merigliano; M Costantini
Journal:  Dis Esophagus       Date:  2017-10-01       Impact factor: 3.429

8.  Wireless pH monitoring in patients with non-cardiac chest pain.

Authors:  Chandra Prakash; Ray E Clouse
Journal:  Am J Gastroenterol       Date:  2006-03       Impact factor: 10.864

9.  Measurement of esophago-gastric junction cross-sectional area and distensibility by an endolumenal functional lumen imaging probe for the diagnosis of gastro-esophageal reflux disease.

Authors:  E Tucker; R Sweis; A Anggiansah; T Wong; E Telakis; K Knowles; J Wright; M Fox
Journal:  Neurogastroenterol Motil       Date:  2013-08-26       Impact factor: 3.598

10.  Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care.

Authors:  R Jones; O Junghard; J Dent; N Vakil; K Halling; B Wernersson; T Lind
Journal:  Aliment Pharmacol Ther       Date:  2009-09-08       Impact factor: 8.171

View more
  2 in total

1.  Optimal Wireless Reflux Monitoring Metrics to Predict Discontinuation of Proton Pump Inhibitor Therapy.

Authors:  Rena Yadlapati; C Prakash Gyawali; Melina Masihi; Dustin A Carlson; Peter J Kahrilas; Billy Darren Nix; Anand Jain; Joseph R Triggs; Michael F Vaezi; Leila Kia; Alexander Kaizer; John E Pandolfino
Journal:  Am J Gastroenterol       Date:  2022-06-10       Impact factor: 12.045

Review 2.  Factors that Impact Day-to-Day Esophageal Acid Reflux Variability and Its Diagnostic Significance for Gastroesophageal Reflux Disease.

Authors:  Steven D Ma; Vandan Patel; Rena Yadlapati
Journal:  Dig Dis Sci       Date:  2022-04-19       Impact factor: 3.487

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.